ANI PHARMACEUTICALS INC ($ANIP)

Apr 13, 26SELLCook Meredith· SR. VP, GENERAL COUNSEL & SEC.500 sh @ $77.95−$39K↗

Mar 13, 26SELLMutz Christopher· HEAD OF RARE DISEASE3,162 sh @ $71.64−$227K↗

Mar 13, 26SELLCook Meredith· SR. VP, GENERAL COUNSEL & SEC.500 sh @ $72.62−$36K↗

Mar 11, 26SELLRowland Thomas Andrew· SVP, HEAD - ESTABLISHED BRANDS4,772 sh @ $74.91−$357K↗

Mar 9, 26SELLDavis Krista· SVP, CHIEF HR OFFICER5,087 sh @ $74.13−$377K↗

Mar 9, 26SELLMutz Christopher· HEAD OF RARE DISEASE3,602 sh @ $74.18−$267K↗

Mar 6, 26SELLMutz Christopher· HEAD OF RARE DISEASE2,121 sh @ $74.22−$157K↗

Mar 6, 26SELLDavis Krista· SVP, CHIEF HR OFFICER1,485 sh @ $75.00−$111K↗

Mar 5, 26SELLCAREY STEPHEN P.· SVP & CFO4,000 sh @ $75.56−$302K↗

Mar 5, 26SELLCAREY STEPHEN P.· SVP & CFO3,312 sh @ $75.42−$250K↗

Mar 3, 26SELLWalsh Patrick D· 6,000 sh @ $74.23−$445K↗

Mar 3, 26SELLGutwerg Ori· SVP, GENERICS2,060 sh @ $76.50−$158K↗

Mar 2, 26SELLMutz Christopher· HEAD OF RARE DISEASE417 sh @ $74.00−$31K↗

Feb 20, 26SELLMutz Christopher· HEAD OF RARE DISEASE5,323 sh @ $78.02−$415K↗

Feb 20, 26SELLDavis Krista· SVP, CHIEF HR OFFICER1,730 sh @ $77.99−$135K↗

Feb 19, 26SELLDavis Krista· SVP, CHIEF HR OFFICER2,084 sh @ $77.53−$162K↗

Feb 13, 26SELLCook Meredith· SR. VP, GENERAL COUNSEL & SEC.500 sh @ $76.80−$38K↗

Feb 12, 26SELLMutz Christopher· HEAD OF RARE DISEASE7,032 sh @ $76.55−$538K↗

$ANIPANI PHARMACEUTICALS INC